New Monograph: COVID-19 – online now!

The first 14 chapters of the COVID-19 Monograph are now online! The story of COVID-19 now seems so familiar: from the first reported case in December 2019, to a pandemic that rapidly changed the world. Respiratory clinicians and scientists were at the forefront of delivering healthcare for people with COVID-19, leading efforts to understand this novel virus and disease, and developing and testing strategies to better prevent and treat it. The pace of knowledge acquisition was rapid but is now maturing. This Monograph provides a timely and valuable state-of-the-art summary of this virus and its consequences to date. It is essential reading for all those involved in the care of people who are or who have been affected by COVID-19.

• Visit books.ersjournals.com to access the book online. And look out for an up-to-date vaccines chapter, which will be added to the issue in early 2022.

ERS International Congress 2022: submit an abstract or clinical case

The European Respiratory Society (ERS) is delighted to announce that the call for abstracts and clinical cases is now open, offering an opportunity to be part of the scientific and educational programme at the ERS International Congress 2022 in Barcelona, Spain. The ERS Congress is a highly regarded annual event in the respiratory calendar. It attracts a global audience and registration numbers have reached 34,000 in recent years. Presenting your work at this event can provide you with international recognition and boost your profile amongst the world's leading respiratory experts. Find out more and submit your abstract before 15 February.

Eosinophilic Lung Diseases – pre-order your print copy

The forthcoming ERS Monograph on Eosinophilic Lung Diseases is now available to pre-order. Guest Edited by David J. Jackson and Michael E. Wechsler, the book will open with an introduction to eosinophil biology, followed by chapters covering differential diagnosis, biomarkers and imaging. It will then move on to consider specific diseases: asthma, COPD, pneumonia, EGPA, allergic fungal diseases and hypereosinophilic syndromes. Closing with a chapter on future prospects, this book will be a great addition to the Monograph series and a welcome resource to respiratory clinicians. Pre-order your print copy at ersbookshop.com before 4 January and receive a €10 discount.